Gene: PTTG2
Official Full Name: pituitary tumor-transforming 2provided by HGNC
Gene Summary: Predicted to enable SH3 domain binding activity. Predicted to be involved in homologous chromosome segregation. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA11373 | PTTG2 Knockout cell line (AC16) | Human | PTTG2 | 1:3-1:4 | negative | Online Inquiry |
| KOA26820 | PTTG2 Knockout cell line (BEAS-2B) | Human | PTTG2 | 1:3~1:4 | negative | Online Inquiry |
| KOA42257 | PTTG2 Knockout cell line (U-2932) | Human | PTTG2 | 1:2-1:4 | negative | Online Inquiry |
| KOA57636 | PTTG2 Knockout cell line (TPC-1) | Human | PTTG2 | 1:5-1:8 | negative | Online Inquiry |
| KOA73064 | PTTG2 Knockout cell line (NCM460) | Human | PTTG2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.